BARTLETT & CO. WEALTH MANAGEMENT LLC
Position in DNLI — Denali Therapeutics Inc.
CIK 2010186
CINCINNATI, OH
Position in DNLI
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$28,800
+$4,035 QoQ
Shares Held
1,500
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARTLETT & CO. WEALTH MANAGEMENT LLC holds $1,178,544 across 17 Biotechnology names. DNLI ranks #5 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
11,100 | $528,027 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
362 | $279,695 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
570 | $254,527 | |
| 4 | INCY |
Incyte Corp
|
354 | $33,318 | |
| 5 | DNLI |
Denali Therapeutics Inc.
This page
|
1,500 | $28,800 | |
| 6 | CADL |
Candel Therapeutics, Inc.
|
3,520 | $17,248 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
1,071 | $10,088 | |
| 8 | OCGN |
Ocugen, Inc.
|
5,300 | $9,593 |
All Filings in DNLI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,800 | 1,500 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $24,765 | 1,500 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $21,780 | 1,500 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $20,985 | 1,500 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $20,392 | 1,500 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $30,570 | 1,500 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $43,695 | 1,500 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $34,830 | 1,500 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $30,780 | 1,500 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $32,190 | 1,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $511,624 | 24,800 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $635,645 | 21,540 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $496,281 | 21,540 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $577,891 | 20,780 | Shares | Sole | 2024-02-14 | |
| 2022-09-30 | $637,738 | 20,780 | Shares | Sole | 2024-02-14 | |
| 2022-06-30 | $544,778 | 18,511 | Shares | Sole | 2024-02-14 | |
| 2022-03-31 | $595,466 | 18,510 | Shares | Sole | 2024-02-14 | |
| 2021-12-31 | $755,657 | 16,943 | Shares | Sole | 2024-02-14 | |
| 2021-09-30 | $75,675 | 1,500 | Shares | Sole | 2024-02-14 | |
| 2021-06-30 | $117,660 | 1,500 | Shares | Sole | 2024-02-14 | |
| 2021-03-31 | $85,650 | 1,500 | Shares | Sole | 2024-02-14 | |
| 2020-12-31 | $167,520 | 2,000 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||